BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Abid Q, Best Rocha A, Larsen CP, Schulert G, Marsh R, Yasin S, Patty-Resk C, Valentini RP, Adams M, Baracco R. APOL1-Associated Collapsing Focal Segmental Glomerulosclerosis in a Patient With Stimulator of Interferon Genes (STING)-Associated Vasculopathy With Onset in Infancy (SAVI). Am J Kidney Dis 2020;75:287-90. [PMID: 31601430 DOI: 10.1053/j.ajkd.2019.07.010] [Cited by in Crossref: 16] [Cited by in F6Publishing: 16] [Article Influence: 5.3] [Reference Citation Analysis]
Number Citing Articles
1 Frémond ML, Crow YJ. STING-Mediated Lung Inflammation and Beyond. J Clin Immunol 2021;41:501-14. [PMID: 33532887 DOI: 10.1007/s10875-021-00974-z] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 4.0] [Reference Citation Analysis]
2 Staels F, Betrains A, Doubel P, Willemsen M, Cleemput V, Vanderschueren S, Corveleyn A, Meyts I, Sprangers B, Crow YJ, Humblet-Baron S, Liston A, Schrijvers R. Adult-Onset ANCA-Associated Vasculitis in SAVI: Extension of the Phenotypic Spectrum, Case Report and Review of the Literature. Front Immunol 2020;11:575219. [PMID: 33133092 DOI: 10.3389/fimmu.2020.575219] [Cited by in Crossref: 2] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
3 Fenaroli P, Rossi GM, Angelotti ML, Antonelli G, Volpi S, Grossi A, Delsante M, Lodi L, Landini S, Romagnani P, Vaglio A. Collapsing Glomerulopathy as a Complication of Type I Interferon-Mediated Glomerulopathy in a Patient With RNASEH2B-Related Aicardi-Goutières Syndrome. Am J Kidney Dis 2021:S0272-6386(21)00532-1. [PMID: 33872687 DOI: 10.1053/j.ajkd.2021.02.330] [Reference Citation Analysis]
4 DeOliveira M, Feeney C, Leahy C, Nystrom S, Howell DN, Farouk SS, Wu M, Olabisi OA, Sparks MA. Collapsing Glomerulopathy in Identical Twins With Lupus and High-Risk Apolipoprotein L1 (APOL1) Genotype. Kidney Int Rep 2021;6:2501-4. [PMID: 34514214 DOI: 10.1016/j.ekir.2021.06.005] [Reference Citation Analysis]
5 Couturier A, Ferlicot S, Chevalier K, Guillet M, Essig M, Jauréguiberry S, Collarino R, Dargelos M, Michaut A, Geri G, Roque-Afonso AM, Zaidan M, Massy ZA. Indirect effects of severe acute respiratory syndrome coronavirus 2 on the kidney in coronavirus disease patients. Clin Kidney J 2020;13:347-53. [PMID: 32695325 DOI: 10.1093/ckj/sfaa088] [Cited by in Crossref: 17] [Cited by in F6Publishing: 18] [Article Influence: 8.5] [Reference Citation Analysis]
6 Zhang PL, Liu ML. Extracellular vesicles mediate cellular interactions in renal diseases-Novel views of intercellular communications in the kidney. J Cell Physiol 2021;236:5482-94. [PMID: 33432614 DOI: 10.1002/jcp.30268] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
7 Xiao AY, Kanaan HD, Lai Z, Li W, Zhang PL. Role of progenitor cell marker CD133 in supporting diagnosis of collapsing glomerulopathy. Int Urol Nephrol 2022. [PMID: 34978023 DOI: 10.1007/s11255-021-03078-0] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
8 Wu H, Larsen CP, Hernandez-Arroyo CF, Mohamed MMB, Caza T, Sharshir M, Chughtai A, Xie L, Gimenez JM, Sandow TA, Lusco MA, Yang H, Acheampong E, Rosales IA, Colvin RB, Fogo AB, Velez JCQ. AKI and Collapsing Glomerulopathy Associated with COVID-19 and APOL 1 High-Risk Genotype. J Am Soc Nephrol. 2020;31:1688-1695. [PMID: 32561682 DOI: 10.1681/asn.2020050558] [Cited by in Crossref: 81] [Cited by in F6Publishing: 62] [Article Influence: 40.5] [Reference Citation Analysis]
9 Dhande IS, Braun MC, Doris PA. Emerging Insights Into Chronic Renal Disease Pathogenesis in Hypertension From Human and Animal Genomic Studies. Hypertension 2021;78:1689-700. [PMID: 34757770 DOI: 10.1161/HYPERTENSIONAHA.121.18112] [Reference Citation Analysis]
10 Boyadzhieva Z, Ruffer N, Burmester G, Pankow A, Krusche M. Effectiveness and Safety of JAK Inhibitors in Autoinflammatory Diseases: A Systematic Review. Front Med 2022;9:930071. [DOI: 10.3389/fmed.2022.930071] [Reference Citation Analysis]
11 Hiraki LT. APOL1 Gene - Implications for Systemic Lupus Erythematosus. J Rheumatol 2020;47:1155-7. [PMID: 32739899 DOI: 10.3899/jrheum.200038] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
12 Dai Y, Liu X, Zhao Z, He J, Yin Q. Stimulator of Interferon Genes-Associated Vasculopathy With Onset in Infancy: A Systematic Review of Case Reports. Front Pediatr 2020;8:577918. [PMID: 33425809 DOI: 10.3389/fped.2020.577918] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
13 Smith KD, Akilesh S. Pathogenesis of coronavirus disease 2019-associated kidney injury. Curr Opin Nephrol Hypertens 2021;30:324-31. [PMID: 33767060 DOI: 10.1097/MNH.0000000000000708] [Cited by in Crossref: 2] [Article Influence: 2.0] [Reference Citation Analysis]
14 Cetin Gedik K, Lamot L, Romano M, Demirkaya E, Piskin D, Torreggiani S, Adang LA, Armangue T, Barchus K, Cordova DR, Crow YJ, Dale RC, Durrant KL, Eleftheriou D, Fazzi EM, Gattorno M, Gavazzi F, Hanson EP, Lee-Kirsch MA, Montealegre Sanchez GA, Neven B, Orcesi S, Ozen S, Poli MC, Schumacher E, Tonduti D, Uss K, Aletaha D, Feldman BM, Vanderver A, Brogan PA, Goldbach-Mansky R. The 2021 European Alliance of Associations for Rheumatology/American College of Rheumatology Points to Consider for Diagnosis and Management of Autoinflammatory Type I Interferonopathies: CANDLE/PRAAS, SAVI, and AGS. Arthritis Rheumatol 2022;74:735-51. [PMID: 35315249 DOI: 10.1002/art.42087] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
15 Ravaglia F, Melica ME, Angelotti ML, De Chiara L, Romagnani P, Lasagni L. The Pathology Lesion Patterns of Podocytopathies: How and why? Front Cell Dev Biol 2022;10:838272. [DOI: 10.3389/fcell.2022.838272] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
16 Lodi L, Mastrolia MV, Bello F, Rossi GM, Angelotti ML, Crow YJ, Romagnani P, Vaglio A. Type I interferon-related kidney disorders. Kidney Int 2022:S0085-2538(22)00213-7. [PMID: 35339535 DOI: 10.1016/j.kint.2022.02.031] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
17 Bruggeman LA, Sedor JR, O'Toole JF. Apolipoprotein L1 and mechanisms of kidney disease susceptibility. Curr Opin Nephrol Hypertens 2021;30:317-23. [PMID: 33767059 DOI: 10.1097/MNH.0000000000000704] [Reference Citation Analysis]
18 Larsen CP, Wickman TJ, Braga JR, Matute-trochez LA, Hasty AE, Buckner LR, Arthur JM, Haun RS, Velez JCQ. APOL1 Risk Variants and Acute Kidney Injury in Black Americans with COVID-19. CJASN 2021;16:1790-6. [DOI: 10.2215/cjn.01070121] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
19 Cetin Gedik K, Lamot L, Romano M, Demirkaya E, Piskin D, Torreggiani S, Adang LA, Armangue T, Barchus K, Cordova DR, Crow YJ, Dale RC, Durrant KL, Eleftheriou D, Fazzi EM, Gattorno M, Gavazzi F, Hanson EP, Lee-Kirsch MA, Montealegre Sanchez GA, Neven B, Orcesi S, Ozen S, Poli MC, Schumacher E, Tonduti D, Uss K, Aletaha D, Feldman BM, Vanderver A, Brogan PA, Goldbach-Mansky R. The 2021 EULAR and ACR points to consider for diagnosis and management of autoinflammatory type I interferonopathies: CANDLE/PRAAS, SAVI and AGS. Ann Rheum Dis 2022:annrheumdis-2021-221814. [PMID: 35086813 DOI: 10.1136/annrheumdis-2021-221814] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 4.0] [Reference Citation Analysis]
20 Goyal R, Singhal PC. APOL1 risk variants and the development of HIV-associated nephropathy. FEBS J 2021;288:5586-97. [PMID: 33340240 DOI: 10.1111/febs.15677] [Reference Citation Analysis]
21 Ma M, Mazumder S, Kwak H, Adams M, Gregory M. Case Report: Acute Thrombotic Microangiopathy in a Patient with STING-Associated Vasculopathy with Onset in Infancy (SAVI). J Clin Immunol 2020;40:1111-5. [PMID: 32860170 DOI: 10.1007/s10875-020-00850-2] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.5] [Reference Citation Analysis]
22 Wang Y, Wang F, Zhang X. STING-associated vasculopathy with onset in infancy: a familial case series report and literature review. Ann Transl Med 2021;9:176. [PMID: 33569478 DOI: 10.21037/atm-20-6198] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
23 Landman SL, Ressing ME, van der Veen AG. Balancing STING in antimicrobial defense and autoinflammation. Cytokine Growth Factor Rev 2020;55:1-14. [PMID: 32563552 DOI: 10.1016/j.cytogfr.2020.06.004] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
24 Akilesh S, Nast CC, Yamashita M, Henriksen K, Charu V, Troxell ML, Kambham N, Bracamonte E, Houghton D, Ahmed NI, Chong CC, Thajudeen B, Rehman S, Khoury F, Zuckerman JE, Gitomer J, Raguram PC, Mujeeb S, Schwarze U, Shannon MB, De Castro I, Alpers CE, Najafian B, Nicosia RF, Andeen NK, Smith KD. Multicenter Clinicopathologic Correlation of Kidney Biopsies Performed in COVID-19 Patients Presenting With Acute Kidney Injury or Proteinuria. Am J Kidney Dis 2021;77:82-93.e1. [PMID: 33045255 DOI: 10.1053/j.ajkd.2020.10.001] [Cited by in Crossref: 23] [Cited by in F6Publishing: 33] [Article Influence: 11.5] [Reference Citation Analysis]